Accumulation of selected carotenoids, α-tocopherol and retinol in human ovarian carcinoma ascitic fluid

被引:15
|
作者
Schweigert, FJ
Raila, J
Sehouli, J
Buscher, U
机构
[1] Univ Potsdam, Inst Nutr Sci, Dept Physiol & Pathophysiol, DE-14558 Potsdam, Germany
[2] Charite, Dept Gynecol & Obstet, Berlin, Germany
[3] Charite, Dept Obstet, Berlin, Germany
关键词
retinol; alpha-tocopherol; carotenoids; cancer; ovarian carcinoma; plasma; ascites;
D O I
10.1159/000080457
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with severe forms of cancer are reported to have reduced concentrations of micronutrients in plasma due to the chronic reduction of food intake and an increased metabolism of these components. The purpose of this study was to evaluate if an accumulation of carotenoids, alpha-tocopherol and retinol in malignant ascitic fluid in women with ovarian cancer might contribute to a loss of these components from plasma. Methods: Blood and ascitic fluid samples obtained from 21 women with ovarian carcinomas and 17 healthy controls were analyzed for retinol, retinol-binding protein (RBP), alpha-tocopherol and carotenoids. Results: Plasma concentrations of all micronutrients were lower in cancer patients compared to controls. Ascitic fluid concentration of all investigated components was comparable (73-110%) to plasma. While the mean concentration of retinol in malignant ascites represented 73% of that in plasma, the concentration of RBP was less than 10% resulting in an increased mean molar ratio of retinol to RBP from 1.18 to 10.5. Conclusions: The results suggest that lower plasma concentrations of micronutrients in women suffering from ovarian carcinoma are not only caused by a cachexia-induced decrease of food intake and a higher rate of metabolic utilization, but also by a substantial yet not considered transfer from plasma into ascitic fluid possibly associated with plasma lipoproteins. This raises questions with regard to the protective function of these plasma components in ascitic fluid, the consequences of paracentesis on an additional supplementation and finally the possibility to use one or a combination of these components as an additional marker to discriminate between benign and malignant ascites. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:241 / 245
页数:5
相关论文
共 50 条
  • [41] Lead accumulation in human ovarian follicular fluid, and in vitro effect of lead on progesterone production by cultured human ovarian granulosa cells
    Paksy, K
    Gáti, I
    Náray, M
    Rajczy, K
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A, 2001, 62 (05) : 359 - 366
  • [42] Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinoma
    Iida, Yasushi
    Aoki, Katsuhiko
    Asakura, Tadashi
    Ueda, Kazu
    Yanaihara, Nozomu
    Takakura, Satoshi
    Yamada, Kyosuke
    Okamoto, Aikou
    Tanaka, Tadao
    Ohkawa, Kiyoshi
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (06) : 2122 - 2130
  • [43] Exosomes derived from ascitic fluid of patients with ovarian carcinoma induce IL-4 gene expression in T lymphocytes
    Sahin, Ergin
    Taylor, Douglas D.
    Taylor, Cicek Gercel
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [44] CYTOLYTIC ACTIVITY OF LYMPHOCYTES-T ISOLATED FROM OVARIAN-CARCINOMA ASCITIC FLUID - ANALYSIS AT THE POPULATION AND CLONAL LEVEL
    BIASSONI, R
    PRIGIONE, I
    DIMARCO, E
    FERRINI, S
    RICERCA IN CLINICA E IN LABORATORIO, 1985, 15 (02): : 177 - 183
  • [45] Ovarian pulmonary-type small cell carcinoma diagnosed by means of ascitic fluid cytology: A case report with immunocytochemical analysis
    Ishikawa, Akira
    Fujisawa, Hiroki
    Yasumura, Naoko
    Kuraoka, Kazuya
    Zaitsu, Junichi
    Saito, Akihisa
    Kan, Arisa
    Iwahiro, Kazue
    Kimura, Fumika
    Nakamura, Hiroko
    Mizunoe, Tomoya
    Taniyama, Kiyomi
    CYTOPATHOLOGY, 2021, 32 (02) : 250 - 252
  • [46] GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELLS IN HUMAN OVARIAN-CARCINOMA ASCITIC FLUID - IDENTIFICATION OF TRANSFORMING GROWTH-FACTOR-BETA AS A SUPPRESSIVE FACTOR
    HIRTE, H
    CLARK, DA
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 32 (05) : 296 - 302
  • [47] THE INTERTUMORAL HETEROGENEITY IN DRUG-SENSITIVITY OF CELLS FROM THE PRIMARY TUMOR AND ASCITIC FLUID IN HUMAN OVARIAN-CANCER
    SERGEEVA, NS
    SVIRIDOVA, IK
    KIRSANOVA, VA
    KURILJAK, OA
    SKOTNIKOVA, OI
    NOVIKOVA, EG
    EKSPERIMENTALNAYA ONKOLOGIYA, 1994, 16 (4-6): : 405 - 410
  • [48] INHIBITORY ACTION OF HUMAN FOLLICULAR-FLUID ON OVARIAN ACCUMULATION OF CYCLIC-AMP
    KRAIEM, Z
    DRUKER, B
    LUNENFELD, B
    JOURNAL OF ENDOCRINOLOGY, 1978, 78 (01) : 161 - 162
  • [49] A folate binding protein in ascitic fluid, serum and ovarian tissue of patients with ovarian adenocarcinoma immunoreacts with antibodies against human milk folate binding protein
    Holm, J
    Hansen, SI
    Hoier-Madsen, M
    Helkjaer, PE
    BIOSCIENCE REPORTS, 1998, 18 (02) : 49 - 57
  • [50] Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma
    Liu, Changmei
    Yang, Fangmei
    TUMOR BIOLOGY, 2015, 36 (09) : 7213 - 7219